Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

This is how it is not "entirely de-risked" at this

Message Board Public Reply | Private Reply | Keep | Replies (5)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154778
(Total Views: 759)
Posted On: 11/24/2021 3:32:39 PM
Posted By: RTB
Re: Evil Rabbit #111062
This is how it is not "entirely de-risked" at this point:
They need to use 50 - 60 million of those shares in the next 5 months to retire the current Fife obligations under the current terms (if the share price remains around $1.25).
They will need to use another 50 million to fund operations for the next 6 months. At least. So, after those 110 million shares, they would be right where they are now. No cash on hand. They can use the other 90 million to fund themselves on a month to month basis. And, who knows how many of those 90 million will be utilized in the short term for compensation and recruiting purposes.

As Ohm surmised, one of the reason for slow trial enrollment in Brazil is/was lack of funding. With the new shares, they will accelerate activity, which is good, but also causes a need for more shares.

All of these new shares keep a lid on the price. Especially because they are being issued at 15% to 25% discounts to sophisticated investors who utilize various strategies, including shorting the stock, to hedge their positions while selling shares (and waiting for them to be registered).

The company has yet to demonstrate it can satisfy FDA submission requirements.

None of the above is insurmountable. But, it all introduces risk.


(6)
(4)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us